Suchergebnisse - "Macrophage activation syndrome"

PubPharm (1.426)

111

Clinical Multicenter Study of Tocilizumab in the Treatment of sJIA-MAS : Clinical multicenter study of interleukin-6 inhibitor in the treatment of systemic juvenile idiopathic arthritis complicated with macrophage activation syndrome

enthalten in: WHO International Clinical Trials Registry Platform | 2023

112

Treatment for macrophage activation syndrome associated with systemic juvenile idiopathic arthritis in Japan

enthalten in: International journal of rheumatic diseases | 2023

von Shimizu, M. | Nishimura, K. | Iwata, N. | +14

113

A Diagnostic Dilemma : Adult-Onset Still's Disease With Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome?

enthalten in: Journal of medical cases | 2023

von Parkash, O. | Anand, A. | Shayuk, M.

114

An Unusual Case of Macrophage Activation Syndrome (MAS)- Hemophagocytic Lymphohistiocytosis (HLH) Triggered by Necrotizing Autoimmune Myopathy

enthalten in: Cureus | 2023

von Brown, T. | Vo, G. | Charoenpong, P.

115

Variation of Diagnostic Approaches and Treatment Practices for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome Among Pediatric Subspecialists

enthalten in: The Journal of pediatrics | 2023

von Carter-Febres, M. | Lozano-Chinga, M. | Thomsen, W. | +3

116

Macrophage Activation Syndrome Complicated by Toxic Epidermal Necrolysis Following SARS-CoV-2 mRNA Vaccination

enthalten in: Journal of clinical immunology | 2023

von Franzblau, L. | Mauskar, M. | Wysocki, C.

117

Reactivation of Parvovirus B19 Infection : An Uncommon Trigger of Macrophage Activation Syndrome in Adult-Onset Still's Disease

enthalten in: Cureus | 2023

von Leelaviwat, N. | Armin, S. | Mekraksakit, P. | +1

118

Systemic Juvenile Idiopathic Arthritis and Secondary Macrophage Activation Syndrome in Latvia from 2009 to 2020 : A Nationwide Retrospective Study

enthalten in: Medicina (Kaunas, Lithuania) | 2023

von Lukjanoviča, K. | Šlēziņa, I. | Dāvidsone, Z. | +3

119

A study to see if a drug called gemtuzumab ozogamicin is a useful treatment for patients with immune disorders called haemophagocytic lymphohistiocytosis (HLH) or macrophage activation syndrome (MAS), or for patients with cancer : A phase II trial to assess the activity of Gemtuzumab Ozogamicin Therapy in Haemophagocytic lymphohistiocytosis (HLH) or Macrophage activation syndrome (MAS) or relapsed/refractory solid tumours (GOTHAM)

enthalten in: WHO International Clinical Trials Registry Platform | 2023

120

A study to see if a drug called gemtuzumab ozogamicin is a useful treatment for patients with immune disorders called haemophagocytic lymphohistiocytosis (HLH) or macrophage activation syndrome (MAS), or for patients with cancer : A phase II trial to assess the activity of Gemtuzumab Ozogamicin Therapy in Haemophagocytic lymphohistiocytosis (HLH) or Macrophage activation syndrome (MAS) or relapsed/refractory solid tumours (GOTHAM)

enthalten in: WHO International Clinical Trials Registry Platform | 2023